(c) 2024 PillSync.com

asprin 25 mg extendedrelease dipyridamole 500 mg

1 INDICATIONS AND USAGE Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. • Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )

glenmark pharmaceuticals inc., usa


8 months ago CAPSULE RED G 405 asprin 25 mg extendedrelease dipyridamole 500 mg

CAPSULE RED G 405

8 months ago CAPSULE RED G 405 asprin 25 mg extendedrelease dipyridamole 500 mg

G 405 CAPSULE RED

16 HOW SUPPLIED/STORAGE AND HANDLING Aspirin and Extended-Release Dipyridamole capsules, 25 mg/200 mg are available as size ‘0el’ empty hard gelatin capsules with a reddish brown opaque cap and a cream opaque body, imprinted with the Glenmark logo ‘G’ on the cap and ‘405’ on the body with black ink. The capsules are filled with light yellow to yellow colored dipyridamole pellets in extended-release form and a white to off-white aspirin tablet in immediate-release form. Aspirin and Extended-Release Dipyridamole capsules, 25 mg/200 mg are supplied in unit-of-use bottles of 30 capsules (NDC 68462-405-30) and unit-of-use bottles of 60 capsules (NDC 68462-405-60). Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from excessive moisture.


More pills like CAPSULE G 405












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site